NEWS & EVENTS 
SPECIALTY CARE
MCT2D Learning Community Event: MASLD Guidelines for People With Diabetes
Updated: 02/23/26
Watch the Recorded Talk
February 20, 2026
In February 2026, the learning community webinar featured Caroline Richardson MD, Chair of Family Medicine at Warren Alpert Medical School of Brown University And Care New England, Co-author of 2025 ADA MASLD Consensus Statement.
Dr. Caroline Richardson, Chair of Family Medicine at Brown University, presented on metabolic-associated steatotic liver disease (MASLD) and its connection to type 2 diabetes. She explained the updated terminology and screening guidelines, emphasizing the importance of FIB4 calculations and fibroscan tests for detecting advanced fibrosis in patients with diabetes. Dr. Richardson discussed treatment options, including GLP-1 agonists, pioglitazone, and alcohol use disorder medications, while highlighting the need for aggressive management of metabolic risk factors. She also covered the role of hepatitis B and C screening, as well as strategies for hepatocellular carcinoma surveillance in patients with cirrhosis. The presentation concluded with a review of top actions for managing MASLD in type 2 diabetes patients, including medication choices and screening recommendations.
Subscribe to the Bi-monthly MCT2D Newsletter
We deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.